Skip to main content

Apolipoprotein E and Alzheimer’s disease

  • Chapter
HDL Deficiency and Atherosclerosis

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 174))

  • 38 Accesses

Abstract

Apolipoprotein (apo) E, a 34 000 molecular weight protein that is the product of a single gene on chromosome 19 (for review, see ref. 1), exists in three major forms. Its heterogeneity results from a single amino acid substitution at residue 112 or 158. The common isoform, apoE3, has cysteine at residue 112 and arginine at residue 158. The apoE4 isoform, which has been linked to Alzheime’s disease, differs from apoE3 only at residue 112, where it possesses arginine. The apoE2 isoform, associated with type III hyperlipoproteinaemia1, differs from apoE3 only at residue 158, where it possesses cysteine. Apolipoproteins E3 and E4 bind normally to the low density lipoprotein (LDL) receptor, whereas apoE2 does not.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240: 622–30.

    Article  PubMed  CAS  Google Scholar 

  2. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA. 1985; 82: 203–7.

    Article  PubMed  CAS  Google Scholar 

  3. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985; 76: 1501–13.

    Article  PubMed  CAS  Google Scholar 

  4. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta. 1987; 917: 148–61.

    PubMed  CAS  Google Scholar 

  5. Pitas RE, Boyles JK, Lee SH, Hui DY, Weisgraber KH. Lipoproteins and their receptors in the central nervous system: characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem. 1987; 262: 14352–60.

    PubMed  CAS  Google Scholar 

  6. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE. Effects of apolipoprotein E, ß-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res. 1992; 33: 1677–88.

    PubMed  CAS  Google Scholar 

  7. Müller HW, Gebicke-Härter PJ, Hangen DH, Shooter EM. A specific 37,000- dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science. 1985; 228: 499–501.

    Article  PubMed  Google Scholar 

  8. Ignatius MJ, Gebicke-Härter PJ, Skene JHP, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA. 1986; 83: 1125–9.

    Article  PubMed  CAS  Google Scholar 

  9. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989; 83: 1015–31.

    Article  PubMed  CAS  Google Scholar 

  10. Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. Lipoprotein uptake by neuronal growth cones in vitro. Science. 1987; 236: 959–62.

    Article  PubMed  CAS  Google Scholar 

  11. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993; 43: 1467–72.

    PubMed  CAS  Google Scholar 

  12. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993; 261: 921–3.

    Article  PubMed  CAS  Google Scholar 

  13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984; 34: 939–44.

    PubMed  CAS  Google Scholar 

  14. Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron. 1991; 6: 487–98.

    Article  PubMed  CAS  Google Scholar 

  15. Crowther RA. Tau protein and paired helical filaments of Alzheimer’s disease. Curr Opin Struct Biol. 1993; 3: 202–6.

    Article  CAS  Google Scholar 

  16. Roses AD. The Alzheimer diseases. Curr Neurol. 1994; 14: 111–41.

    Google Scholar 

  17. Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol. 1994; 5: 110–16.

    Article  PubMed  CAS  Google Scholar 

  18. Weisgraber KH, Pitas RE, Mahley RW. Lipoproteins, neurobiology, and Alzheimer’s disease: structure and function of apolipoprotein E. Curr Opin Struct Biol. 1994; 4: 507–15.

    Article  CAS  Google Scholar 

  19. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to P-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993; 90: 1977–81.

    Article  PubMed  CAS  Google Scholar 

  20. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid (3 peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993; 90: 8098–102.

    Article  PubMed  CAS  Google Scholar 

  21. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with p amyloid peptide of Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994; 94: 860–9.

    Article  PubMed  CAS  Google Scholar 

  22. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. Amyloid-associated proteins oci- antichymotrypsin and apolipoprotein E promote assembly of Alzheimer P-protein into filaments. Nature. 1994; 372: 92–4.

    CAS  Google Scholar 

  23. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994; 125: 163–71.

    Article  PubMed  CAS  Google Scholar 

  24. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994; 264: 850–2.

    Article  PubMed  CAS  Google Scholar 

  25. Nathan BP, Bellosta S, Mahley RW, Pitas RE. Apolipoprotein E3- and E4-induced differences in neurite outgrowth are associated with differences in the subcellular localization of apolipoprotein E. Soc Neurosci. 1994;20(Part 2): 1033 (abstr.).

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Kluwer Academic Publishers

About this chapter

Cite this chapter

Mahley, R.W. (1995). Apolipoprotein E and Alzheimer’s disease. In: Assmann, G. (eds) HDL Deficiency and Atherosclerosis. Developments in Cardiovascular Medicine, vol 174. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6585-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6585-3_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6587-7

  • Online ISBN: 978-94-011-6585-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics